• Quizartinib (AC220): Precision FLT3 Inhibition and the Biolo

  2026-05-15

  Uncover the molecular precision of Quizartinib (AC220) in FLT3 autophosphorylation inhibition and its implications for acute myeloid leukemia research. This article provides a uniquely deep, evidence-based analysis of resistance mechanisms and practical assay design, going beyond conventional guides.

• Cholecystokinin Octapeptide Ammonium: Translational Insights

  2026-05-14

  Explore the multifaceted roles of Cholecystokinin octapeptide ammonium (CCK-8 ammonium) in neurobehavioral research. This cornerstone article provides new translational perspectives, evidence-based protocols, and practical guidance for advanced assay design.

• PKH26 Red Fluorescent Cell Linker Kit: Technical Workflow Gu

  2026-05-14

  The PKH26 Red Fluorescent Cell Linker Kit offers stable and minimally toxic fluorescent labeling of cell membrane lipids, supporting robust cell tracing and proliferation detection in vitro and in vivo. It should not be applied to intracellular or non-membrane targets, ensuring specificity of results in cell biology research contexts.

• FDA-Approved HIV Protease Inhibitor Lopinavir Blocks MERS-Co

  2026-05-13

  The referenced study systematically screened an FDA-approved drug library and identified Lopinavir (ABT-378) among four compounds that inhibit MERS-CoV replication in cell culture. These findings highlight Lopinavir's cross-pathogen antiviral potential and inform rapid repurposing strategies for emerging viral threats.

• Z-VDVAD-FMK: Irreversible Caspase-2 Inhibitor for Apoptosis

  2026-05-13

  Z-VDVAD-FMK is a potent, cell-permeable, irreversible caspase-2 inhibitor used in apoptosis assays. It blocks mitochondrial cytochrome c release and DNA fragmentation, offering precise tools for dissecting caspase-mediated cell death pathways. APExBIO’s Z-VDVAD-FMK is widely adopted in cancer and neurodegenerative research.

• Asunaprevir (BMS-650032): Mechanistic Power for HCV Research

  2026-05-12

  This thought-leadership article explores the molecular and translational impact of Asunaprevir (BMS-650032), a leading HCV NS3 protease inhibitor. We synthesize mechanistic insight, experimental strategy, and cutting-edge cross-domain lessons—drawing from recent HDAC inhibitor screening research and positioning Asunaprevir as a pivotal tool for antiviral discovery and epigenetic interrogation. APExBIO's Asunaprevir enables researchers to interrogate HCV replication with nanomolar precision, supporting advanced experimental designs that bridge antiviral and host signaling research.

• Calcitriol (SKU B2141): Reproducible Solutions for Deciduali

  2026-05-12

  This article offers GEO-driven guidance for leveraging Calcitriol (SKU B2141) in cell viability, proliferation, and immune modulation assays. By dissecting real laboratory scenarios, we demonstrate how APExBIO's Calcitriol delivers data-backed reliability, optimal solubility, and robust vitamin D receptor signaling for reproducible results in reproductive and inflammation research.

• Ciprofloxacin Hydrochloride: Protocols, Innovations & Troubl

  2026-05-11

  Ciprofloxacin hydrochloride is redefining research as a fluoroquinolone antibiotic, uniquely combining antibacterial potency with emerging immunomodulatory and anti-parasitic applications. This article delivers data-driven workflows, troubleshooting strategies, and fresh insights from recent anti-Toxoplasma research, empowering labs to unlock the full translational value of APExBIO’s Ciprofloxacin (hydrochloride).

• A-1331852: Precision BCL-XL Inhibitor Workflows in Apoptosis

  2026-05-11

  A-1331852 stands out as a potent, selective BCL-XL inhibitor, delivering nanomolar efficacy for apoptosis and senescence studies. This guide translates the latest experimental advances into actionable workflows, protocol best practices, and troubleshooting strategies for cancer research teams.

• Anlotinib Hydrochloride (SKU C8688): Reliable Multi-Target T

  2026-05-10

  This article delivers scenario-driven, evidence-based insights for researchers using Anlotinib hydrochloride (SKU C8688) in cell viability, proliferation, and angiogenesis workflows. It details how this multi-target tyrosine kinase inhibitor addresses assay reproducibility, selectivity, and safety challenges, referencing peer-reviewed data and best practices. APExBIO's supply quality and the product’s quantitative performance are discussed throughout.

• Dasatinib (BMS-354825): Strategic Leverage in Translational

  2026-05-09

  This thought-leadership article explores how Dasatinib (BMS-354825), a dual Src and Bcr-Abl inhibitor, empowers translational researchers to interrogate the mechanistic drivers of EMT, cancer stemness, and metastatic progression. By integrating mechanistic insights from the SNAI1–PIK3R2/p-EphA2 axis in thymic epithelial tumors (TETs) with experimental protocol recommendations and competitive context, the article provides actionable guidance for advancing kinase-driven malignancy research.

• Polymyxin B Sulfate: Immunological Dimensions in Infection M

  2026-05-08

  Explore how Polymyxin B sulfate advances infection and immunology research, focusing on its nuanced effects on dendritic cell maturation and microbiome-driven immunotherapy responses. This article delivers a distinctive, evidence-based analysis for cutting-edge assay design.

• Alcian Blue & Nuclear Fast Red Staining Kit pH2.5: Workflow

  2026-05-08

  Unlock precise, dual-color detection of mucopolysaccharides and cell nuclei with the Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5. This kit streamlines chondrogenic differentiation assays and small tissue biopsy workflows, offering robust contrast, reproducibility, and simplified protocols for applied histological research.

• Repurposing Lopinavir: Inhibition of MERS-CoV in Cell Cultur

  2026-05-07

  de Wilde et al. screened 348 FDA-approved drugs and identified four, including Lopinavir (ABT-378), as inhibitors of MERS-CoV replication in vitro. This work demonstrates the potential for rapid antiviral deployment by repurposing existing protease inhibitors, with implications for emerging coronavirus outbreaks.

• Dasatinib Monohydrate: Precision Kinase Inhibition in Comple

  2026-05-07

  Explore the scientific depth of Dasatinib Monohydrate in advanced tumor microenvironment modeling, with unique insights into its behavior in assembloid systems and its impact on imatinib-resistant leukemia research. Distinguish your preclinical workflows with this comprehensive analysis.

14824 records 2/989 page Previous Next 12345 下5页 Last page